{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:26:08Z","timestamp":1792599968787,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005014","name":"Avicenna Research Institute","doi-asserted-by":"publisher","award":["960205-012"],"award-info":[{"award-number":["960205-012"]}],"id":[{"id":"10.13039\/501100005014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["97-03-87-40182"],"award-info":[{"award-number":["97-03-87-40182"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s12282-022-01393-7","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T16:03:17Z","timestamp":1660838597000},"page":"1121-1132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A novel ADC targeting cell surface fibromodulin in a mouse model of triple-negative breast cancer"],"prefix":"10.1007","volume":"29","author":[{"given":"Mozhan","family":"Haji Ghaffari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miganoosh","family":"Simonian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Mirzadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Nejadmoghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Ebrahimnezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazaleh","family":"Fazli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramina","family":"Fatemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali-Ahmad","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5370-3111","authenticated-orcid":false,"given":"Mohammadali","family":"Mazloomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hodjattallah","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,18]]},"reference":[{"issue":"4","key":"1393_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","volume":"9","author":"C Mattiuzzi","year":"2019","unstructured":"Mattiuzzi C, Lippi G. Current cancer epidemiology. J Epidemiol Glob Health. 2019;9(4):217.","journal-title":"J Epidemiol Glob Health"},{"issue":"11","key":"1393_CR2","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/cncr.29258","volume":"121","author":"HK Weir","year":"2015","unstructured":"Weir HK, Thompson TD, Soman A, M\u00f8ller B, Leadbetter S. The past, present, and future of cancer incidence in the United States: 1975 through 2020. Cancer. 2015;121(11):1827\u201337.","journal-title":"Cancer"},{"issue":"3","key":"1393_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"1\u20132","key":"1393_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/elsc.202000027","volume":"21","author":"Y Si","year":"2021","unstructured":"Si Y, Xu Y, Guan J, Chen K, Kim S, Yang ES, et al. Anti-EGFR antibody-drug conjugate for triple-negative breast cancer therapy. Eng Life Sci. 2021;21(1\u20132):37\u201344.","journal-title":"Eng Life Sci"},{"issue":"3","key":"1393_CR5","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1016\/S1470-2045(19)30026-9","volume":"20","author":"FJ Esteva","year":"2019","unstructured":"Esteva FJ, Hubbard-Lucey VM, Tang J, Pusztai L. Immunotherapy and targeted therapy combinations in metastatic breast cancer. Lancet Oncol. 2019;20(3):e175\u201386.","journal-title":"Lancet Oncol"},{"issue":"6","key":"1393_CR6","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1007\/s11033-018-4427-x","volume":"45","author":"I Kimiz-Gebologlu","year":"2018","unstructured":"Kimiz-Gebologlu I, Gulce-Iz S, Biray-Avci C. Monoclonal antibodies in cancer immunotherapy. Mol Biol Rep. 2018;45(6):2935\u201340.","journal-title":"Mol Biol Rep"},{"issue":"9","key":"1393_CR7","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nbt0905-1073","volume":"23","author":"JM Reichert","year":"2005","unstructured":"Reichert JM, Rosensweig CJ, Faden LB, Dewitz MC. Monoclonal antibody successes in the clinic. Nat Biotechnol. 2005;23(9):1073\u20138.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"1393_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/antib9030034","volume":"9","author":"D Zahavi","year":"2020","unstructured":"Zahavi D, Weiner L. Monoclonal antibodies in cancer therapy. Antibodies. 2020;9(3):34.","journal-title":"Antibodies"},{"issue":"1","key":"1393_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1021\/ar700108g","volume":"41","author":"RV Chari","year":"2008","unstructured":"Chari RV. Targeted cancer therapy: conferring specificity to cytotoxic drugs. Acc Chem Res. 2008;41(1):98\u2013107.","journal-title":"Acc Chem Res"},{"issue":"1","key":"1393_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/1541-7786.MCR-19-0582","volume":"18","author":"P Khongorzul","year":"2020","unstructured":"Khongorzul P, Ling CJ, Khan FU, Ihsan AU, Zhang J. Antibody\u2013drug conjugates: a comprehensive review. Mol Cancer Res. 2020;18(1):3\u201319.","journal-title":"Mol Cancer Res"},{"issue":"19","key":"1393_CR11","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1056\/NEJMoa1209124","volume":"367","author":"S Verma","year":"2012","unstructured":"Verma S, Miles D, Gianni L, Krop IE, Welslau M, Baselga J, et al. Trastuzumab emtansine for HER2-positive advanced breast cancer. N Engl J Med. 2012;367(19):1783\u201391.","journal-title":"N Engl J Med"},{"key":"1393_CR12","unstructured":"Congreve S, Faris Elias R, Tidestav G, Zafranian v. Antibody drug conjugates (ADC): current status and mapping of ADC: s in clinical programs, 2018. http:\/\/urn.kb.se\/resolve?urn=urn:nbn:se:uu:diva-352917"},{"issue":"10","key":"1393_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/onco.13878","volume":"26","author":"LM Spring","year":"2021","unstructured":"Spring LM, Nakajima E, Hutchinson J, Viscosi E, Blouin G, Weekes C, et al. Sacituzumab govitecan for metastatic triple-negative breast cancer: clinical overview and management of potential toxicities. Oncologist. 2021;26(10):827\u201334.","journal-title":"Oncologist"},{"issue":"7","key":"1393_CR14","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1158\/1078-0432.CCR-20-3119","volume":"27","author":"S Wahby","year":"2021","unstructured":"Wahby S, Fashoyin-Aje L, Osgood CL, Cheng J, Fiero MH, Zhang L, et al. FDA approval summary: accelerated approval of sacituzumab govitecan-hziy for third-line treatment of metastatic triple-negative breast cancer. Clin Cancer Res. 2021;27(7):1850\u20134.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1393_CR15","first-page":"6","volume":"16","author":"D Romero","year":"2019","unstructured":"Romero D. Benefit in patients with PD-L1-positive TNBC. Nat Rev Clin Oncol. 2019;16(1):6\u20136.","journal-title":"Nat Rev Clin Oncol"},{"key":"1393_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-0814-8","volume-title":"Cell-extracellular matrix interactions in cancer","author":"R Zent","year":"2010","unstructured":"Zent R, Pozzi A. Cell-extracellular matrix interactions in cancer. Berlin: Springer; 2010."},{"issue":"6","key":"1393_CR17","doi-asserted-by":"publisher","first-page":"H3650","DOI":"10.1152\/ajpheart.00772.2007","volume":"293","author":"L Krishnan","year":"2007","unstructured":"Krishnan L, Hoying JB, Nguyen H, Song H, Weiss JA. Interaction of angiogenic microvessels with the extracellular matrix. Am J Physiol-Heart Circ Physiol. 2007;293(6):H3650\u20138.","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"3","key":"1393_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1272\/jnms.72.137","volume":"72","author":"Z Naito","year":"2005","unstructured":"Naito Z. The role of small leucine-rich proteoglycan (SLRP) family in pathological lesions and cancer cell growth. J Nippon Med Sch. 2005;72(3):137\u201345.","journal-title":"J Nippon Med Sch"},{"issue":"19","key":"1393_CR19","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1111\/j.1742-4658.2010.07797.x","volume":"277","author":"RV Iozzo","year":"2010","unstructured":"Iozzo RV, Schaefer L. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J. 2010;277(19):3864\u201375.","journal-title":"FEBS J"},{"issue":"2","key":"1393_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0002-9440(10)64555-5","volume":"157","author":"C Soo","year":"2000","unstructured":"Soo C, Hu F-Y, Zhang X, Wang Y, Beanes SR, Lorenz HP, et al. Differential expression of fibromodulin, a transforming growth factor-\u03b2 modulator, in fetal skin development and scarless repair. Am J Pathol. 2000;157(2):423\u201333.","journal-title":"Am J Pathol"},{"issue":"8","key":"1393_CR21","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1074\/jbc.M110.168682","volume":"286","author":"Y-H Lee","year":"2011","unstructured":"Lee Y-H, Schiemann WP. Fibromodulin suppresses nuclear factor-\u03bab activity by inducing the delayed degradation of IKBA via a JNK-dependent pathway coupled to fibroblast apoptosis. J Biol Chem. 2011;286(8):6414\u201322.","journal-title":"J Biol Chem"},{"issue":"6","key":"1393_CR22","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.3892\/ol.2017.5960","volume":"13","author":"L DawoodyNejad","year":"2017","unstructured":"DawoodyNejad L, Biglari A, Annese T, Ribatti D. Recombinant fibromodulin and decorin effects on NF-\u03baB and TGF\u03b21 in the 4T1 breast cancer cell line. Oncol Lett. 2017;13(6):4475\u201380.","journal-title":"Oncol Lett"},{"issue":"2","key":"1393_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5301\/jbm.5000184","volume":"31","author":"A Bettin","year":"2016","unstructured":"Bettin A, Reyes I, Reyes N. Gene expression profiling of prostate cancer-associated genes identifies fibromodulin as potential novel biomarker for prostate cancer. Int J Biol Markers. 2016;31(2):153\u201362.","journal-title":"Int J Biol Markers"},{"issue":"1","key":"1393_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3233\/CBM-150555","volume":"16","author":"N Reyes","year":"2016","unstructured":"Reyes N, Benedetti I, Bettin A, Rebollo J, Geliebter J. The small leucine rich proteoglycan fibromodulin is overexpressed in human prostate epithelial cancer cell lines in culture and human prostate cancer tissue. Cancer Biomark. 2016;16(1):191\u2013202.","journal-title":"Cancer Biomark"},{"issue":"19","key":"1393_CR25","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1038\/sj.onc.1209305","volume":"25","author":"C Colin","year":"2006","unstructured":"Colin C, Baeza N, Bartoli C, Fina F, Eudes N, Nanni I, et al. Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization. Oncogene. 2006;25(19):2818\u201326.","journal-title":"Oncogene"},{"issue":"2","key":"1393_CR26","first-page":"127","volume":"16","author":"L Farahi","year":"2019","unstructured":"Farahi L, Ghaemimanesh F, Milani S, Razavi SM, Hadavi R, Bayat AA, et al. GPI-anchored fibromodulin as a novel target in chronic lymphocytic leukemia: diagnostic and therapeutic implications. Iran J Immunol. 2019;16(2):127\u201341.","journal-title":"Iran J Immunol"},{"key":"1393_CR27","doi-asserted-by":"publisher","DOI":"10.22037\/uj.v18i.6461","author":"A-A Bayat","year":"2021","unstructured":"Bayat A-A, Sadeghi N, Salimi A, Fazli G, Nowroozi MR, Moghadam SO, et al. The association of cell surface fibromodulin expression and bladder carcinoma. Urol J. 2021. https:\/\/doi.org\/10.22037\/uj.v18i.6461.","journal-title":"Urol J"},{"issue":"4","key":"1393_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2141.2010.08362.x","volume":"151","author":"A Choudhury","year":"2010","unstructured":"Choudhury A, Derkow K, Daneshmanesh AH, Mikaelsson E, Kiaii S, Kokhaei P, et al. Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells. Br J Haematol. 2010;151(4):327\u201335.","journal-title":"Br J Haematol"},{"key":"1393_CR29","first-page":"1","volume":"124","author":"AI Riggio","year":"2020","unstructured":"Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer. 2020;124:1\u201314.","journal-title":"Br J Cancer"},{"issue":"5","key":"1393_CR30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.5732\/cjc.012.10301","volume":"32","author":"X-L Bi","year":"2013","unstructured":"Bi X-L, Yang W. Biological functions of decorin in cancer. Chin J Cancer. 2013;32(5):266.","journal-title":"Chin J Cancer"},{"issue":"1","key":"1393_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-019-0870-6","volume":"19","author":"MH Pourhanifeh","year":"2019","unstructured":"Pourhanifeh MH, Mohammadi R, Noruzi S, Hosseini SA, Fanoudi S, Mohamadi Y, et al. The role of fibromodulin in cancer pathogenesis: implications for diagnosis and therapy. Cancer Cell Int. 2019;19(1):1\u20139.","journal-title":"Cancer Cell Int"},{"key":"1393_CR32","doi-asserted-by":"crossref","unstructured":"Mikaelsson E, et al. Fibromodulin, an extracellular matrix protein: characterization of its unique gene\u00a0and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Blood. 2005;105(12):4828-4835.","DOI":"10.1182\/blood-2004-10-3941"},{"key":"1393_CR33","volume-title":"Seminars in nuclear medicine","author":"SJ DeNardo","year":"2005","unstructured":"DeNardo SJ. Radioimmunodetection and therapy of breast cancer. In: Seminars in nuclear medicine. Amsterdam: Elsevier; 2005."}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-022-01393-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-022-01393-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-022-01393-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T14:46:55Z","timestamp":1666450015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-022-01393-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,18]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1393"],"URL":"https:\/\/doi.org\/10.1007\/s12282-022-01393-7","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,18]]},"assertion":[{"value":"15 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of the ethics committee of Tehran University of Medical Sciences. (Approval number: IR.TUMS.VCR.REC.1397.1079).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}